2024-09-25 08:30Financial Performance - The unaudited condensed consolidated results for the six months ended June 30, 2024, show a significant increase in revenue compared to the same period in 2023[8]. - The Group reported a profit of HKD 150 million, representing a 20% increase year-on-year[8]. - Revenue for the six months ended June 30, 2024, was HK$3,894.9 million, representing a 10.9% increase from HK$3,512.9 million in the same period of 2023[9]. - Total income for the period was HK$3,972.5 million, with cost of sales and other direct costs amounting to HK$1,459.0 million, resulting in a gross profit of HK$2,513.5 million[9]. - The company reported a loss for the period of HK$108.2 million, compared to a loss of HK$25.8 million in the same period of 2023, indicating a significant decline in profitability[11]. - Basic and diluted loss per share for the period was HK$0.06, compared to HK$0.05 in the previous year[9]. - The company reported a total comprehensive expense of HK$137.2 million for the period, compared to HK$1,155.5 million in the same period of 2023, indicating a significant reduction in overall losses[11]. - The company reported a profit before taxation of HK$55.1 million for the period, compared to a loss of HK$108.2 million in the previous year[63]. - Profit before taxation for the six months ended June 30, 2024, was HK$ 105.3 million, compared to HK$ 67.9 million in 2023, representing a significant increase[82]. Revenue Segments - Revenue from contracts with customers for the six months ended June 30, 2024, was HK$1,531.6 million, a 44% increase from HK$1,063.7 million in 2023[60]. - The healthcare services segment generated revenue of HK$800.4 million, up from HK$170.9 million in 2023, marking a significant increase of 368%[63]. - Revenue from elderly care services reached HK$98.7 million, compared to HK$54.7 million in the prior year, indicating an increase of approximately 80.5%[75]. - Consumer finance segment revenue was HK$1,567.7 million, showing a slight decrease from HK$1,628.6 million in the previous year[63]. - Sales of completed properties decreased to HK$319.1 million in 2024 from HK$750.3 million in 2023, representing a decline of 57.5%[59]. Market and Operational Outlook - The company has provided an optimistic outlook, projecting a revenue growth of 10% for the next six months[8]. - The Group is expanding its market presence in Southeast Asia, targeting a 25% increase in market share within the next year[8]. - The company aims to enhance operational efficiency, targeting a reduction in costs by 5% through strategic initiatives[8]. - New product launches are expected to contribute an additional HKD 50 million in revenue by the end of the fiscal year[8]. Financial Position and Assets - As of June 30, 2024, total assets amounted to HK$ 83,470.4 million, a decrease from HK$ 86,031.6 million as of December 31, 2023, reflecting a decline of approximately 3.6%[16]. - Net current assets increased to HK$ 15,031.9 million from HK$ 14,240.1 million, representing a growth of about 5.6%[16]. - The company's equity attributable to owners decreased to HK$ 43,322.7 million from HK$ 43,538.9 million, a decline of approximately 0.5%[16]. - Current liabilities rose to HK$ 29,467.9 million, up from HK$ 27,778.0 million, indicating an increase of about 6.1%[16]. - The company’s cash and cash equivalents decreased to HK$ 12,665.9 million from HK$ 14,702.0 million, a decline of about 13.9%[16]. Expenses and Costs - Selling and marketing expenses totaled HK$956.4 million, an increase from HK$845.0 million in the previous year, indicating higher investment in market presence[9]. - Research and development expenses have increased by 30%, focusing on innovative technologies to improve service delivery[8]. - The cost of inventories recognized as expenses was HK$ 604.0 million for 2024, up from HK$ 673.5 million in 2023, indicating a decrease of approximately 10.3%[82]. - Total finance costs for the six months ended June 30, 2024, were HK$ 656.1 million, up from HK$ 612.2 million in the previous year, marking an increase of approximately 7.2%[79]. Dividends and Shareholder Returns - The interim dividend declared is HKD 0.05 per share, reflecting a 10% increase from the previous year[8]. - No interim dividend was declared for the six months ended June 30, 2024, compared to HK$ 412.9 million in dividends recognized in 2023[93]. Financial Assets and Liabilities - The total fair value of financial assets measured at fair value was HK$14,921.3 million as of 30th June 2024[109]. - The Group's financial assets at fair value through profit or loss (FVTPL) included Level 2 debt securities and listed perpetual securities, with fair values derived from quoted prices from pricing services[123]. - The impairment allowance for loans and advances to consumer finance customers was HK$ 10,920.4 million, slightly reduced from HK$ 11,197.0 million in the previous period[195]. - The net unrealized loss on Level 3 financial assets at fair value through profit or loss was HK$ 54.4 million as of June 30, 2024, compared to HK$ 5.6 million in 2023[192]. Accounting Policies and Changes - The Group changed its accounting policy for measuring hospital and other buildings in the PRC from a revaluation model to a cost model, which is expected to provide more reliable information reflecting operational performance[54]. - The application of amendments to HKFRSs in the current interim period has had no material impact on the Group's financial positions and performance[52]. - The Group's accounting policy change does not impact profit or loss or loss per share for the six months ended June 30, 2024[53].